Ist cocamidopropyl pg-dimonium chloride phosphate in der Schwangerschaft sicher?
No harmonised CLP reproductive classification (no H360/H361) is documented for this ingredient in ECHA Annex VI, and there are no SCCS or CIR safety opinions identifying reproductive hazard. No peer‑reviewed reproductive or developmental toxicity data specifically implicating this ingredient were identified in the literature. Dermal cosmetic use implies low but measurable exposure rather than negligible (typical for topically applied surfactants/quaternary salts). Sources consulted: ECHA C&L/Annex VI (no harmonised classification), PubMed (no reproductive/developmental studies found), PubChem/CosIng/EWG (no reproductive flags).
Pregnancy-safe products containing cocamidopropyl pg-dimonium chloride phosphate










Related ingredients
Frequently asked questions
- Ist cocamidopropyl pg-dimonium chloride phosphate in der Schwangerschaft sicher?
- No harmonised CLP reproductive classification (no H360/H361) is documented for this ingredient in ECHA Annex VI, and there are no SCCS or CIR safety opinions identifying reproductive hazard. No peer‑reviewed reproductive or developmental toxicity data specifically implicating this ingredient were identified in the literature. Dermal cosmetic use implies low but measurable exposure rather than negligible (typical for topically applied surfactants/quaternary salts). Sources consulted: ECHA C&L/Annex VI (no harmonised classification), PubMed (no reproductive/developmental studies found), PubChem/CosIng/EWG (no reproductive flags).
- Ist cocamidopropyl pg-dimonium chloride phosphate während des Stillens sicher?
- Same rationale as pregnancy: no evidence of reproductive or lactation-specific toxicity in authoritative sources, and no mechanistic data indicating mammary transfer. Topical use implies low but measurable exposure; therefore breastfeeding exposure considered low.
- Ist cocamidopropyl pg-dimonium chloride phosphate sicher für Babyhaut?
- No infant‑specific hazard data identified. Because infant skin (0–3 yr) has a higher surface‑area‑to‑weight ratio and a less mature barrier, exposure score is increased by +1 versus adult (low → moderate). No evidence was found that infant exposure leads to systemic reproductive/mechanistic effects.
- Wie bewertet VeriMom cocamidopropyl pg-dimonium chloride phosphate?
- VeriMom bewertet cocamidopropyl pg-dimonium chloride phosphate mit 93/100 (keine bekannten Risiken) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu cocamidopropyl pg-dimonium chloride phosphate?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu cocamidopropyl pg-dimonium chloride phosphate basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.